BNP Paribas Financial Markets’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $66.7K | Buy |
|
|||||
|
2025
Q2 | $31.8K | Sell |
|
|||||
|
2025
Q1 | $96.8K | Sell |
|
|||||
|
2024
Q4 | $302K | Buy |
|
|||||
|
2024
Q3 | $74.7K | Buy |
|
|||||
|
2024
Q2 | $36.8K | Sell |
|
|||||
|
2024
Q1 | $597K | Buy |
|
|||||
|
2023
Q4 | $317K | Buy |
|
|||||
|
2023
Q3 | $161K | Buy |
|
|||||
|
2023
Q2 | $85.9K | Sell |
|
|||||
|
2023
Q1 | $137K | Buy |
|
|||||
|
2022
Q4 | $48.5K | Sell |
|
|||||
|
2022
Q3 | $88.7K | Buy |
|
|||||
|
2022
Q2 | $66.9K | Buy |
|
|||||
|
2022
Q1 | $35.4K | Sell |
|
|||||
|
2021
Q4 | $124K | Buy |
|
|||||
|
2021
Q3 | $80.7K | Buy |
|
|||||
|
2021
Q2 | $36K | Sell |
|
|||||
|
2021
Q1 | $58.2K | Buy |
|
|||||
|
2020
Q4 | $52.9K | Sell |
|
|||||
|
2020
Q3 | $62.1K | Buy |
|
|||||
|
2020
Q2 | $11.3K | Sell |
|
|||||
|
2020
Q1 | $102K | Buy |
|
|||||
|
2019
Q4 | $58.9K | Sell |
|
|||||
|
2019
Q3 | $53.5K | Buy |
|
|||||
|
2019
Q2 | $39.2K | Sell |
|
|||||
|
2019
Q1 | $63.5K | Buy |
|
|||||
|
2018
Q4 | $11.3K | Sell |
|
|||||
|
2018
Q3 | $24K | Hold |
|
|||||
|
2018
Q2 | $28.1K | Sell |
|
|||||
|
2018
Q1 | $76K | Buy |
|
|||||
|
2017
Q4 | $60.2K | Buy |
|
|||||
|
2017
Q3 | $26K | Sell |
|
|||||
|
2017
Q2 | $31.1K | Buy |
|
|||||
|
2017
Q1 | $10K | Buy |
|
|||||
|
2016
Q4 | $6.11K | Sell |
|
|||||
|
2016
Q3 | $13.2K | Buy |
|
|||||
|
2016
Q2 | $8.51K | Buy |
|
|||||
|
2016
Q1 | $2.56K | Sell |
|
|||||
|
2015
Q4 | $46.7K | Sell |
|
|||||
|
2015
Q3 | $49.9K | Buy |
|
|||||
|
2015
Q2 | $18.7K | Buy |
|
|||||
|
2015
Q1 | $5.27K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $7.85K | Buy |
|
|||||
|
2014
Q2 | $1.44K | Buy |
|